Qian Qin: Tian Zhang with kidney trial updates at Alliance for Clinical Trials in Oncology Fall 24 meeting
Qian Qin, Assistant Professor at UT Southwestern Medical Center, shared a post on X:
“Dr. Tian Zhang with kidney trial updates at Alliance for Clinical Trials in Oncology Fall 24 meeting, highlighting the STRIKE trial (adjuvant Tivozanib Pembrolizumab) getting close to activation and the PDIGREE trial now completed accrual!”
Tian Zhang, Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center, shared this post, adding:
“Thanks for highlighting Qian Qin!
Alliance for Clinical Trials in Oncology’s kidney cancer trial portfolio is strong. Great to see launching of STRIKE in adjuvant setting, steady enrollment on RADICAL, and PDIGREE in follow-up.
UTSW Simmons Cancer Center has contributed to many of current RCC trials!”
More posts featuring Tian Zhang.
Tian Zhang is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in the diagnosis and treatment of genitourinary malignancies. She has gained an international reputation developing clinical trials in kidney, prostate, and bladder cancers.
She serves as the study chair for PDIGREE, a phase III trial in metastatic renal cell carcinoma. She serves on numerous committees, including as Co-chair of the National Cancer Institute Genitourinary (GU) Steering Committee Renal Task Force and as Chair of the Chinese American Hematologist and Oncologist Network (CAHON) Academic Committee.
She is a member of several ASCO clinical management guidelines committees as well as the Alliance for Clinical Trials in Oncology, GU Oncology, and Immuno-Oncology Committees. She has received multiple peer-reviewed grants, a Resident Research Mentoring Award from Duke, and, notably, the 2021 Cancer Prevention and Research Institute of Texas (CPRIT) Scholar Rising Stars Award.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023